Skyline Builders vs PMA Graphene Technology
CRMN and PMA side by side, both in industrials. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRMN and PMA compare
Skyline Builders grew revenue faster over the last twelve months (8.9% versus −56.8% for PMA Graphene Technology).
Skyline Builders keeps more of each dollar of sales as profit, with a net margin of 18.1% compared with −39.4% at PMA Graphene Technology.
Skyline Builders scores higher on the StockData Score (7 against 0 for PMA Graphene Technology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRMN | PMA |
|---|---|---|
| Size and price | ||
| Share price | $0.974 | $1.26 |
| Change, 1 year | −66.9% | −21.3% |
| Beta (5Y) | 1.72 | 1.99 |
| Employees | 73 | 7 |
| StockData Score | ||
| Total score | 7 (better) | 0 |
| Valuation score | 0 | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 4 (better) | 0 |
| Health score | 2 (better) | 0 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 8.9% (better) | −56.8% |
| Net income growth (TTM) | 1146% | – |
| EPS growth (TTM) | −836% | – |
| Profitability | ||
| Gross margin | 6.6% (better) | −18.4% |
| Operating margin | −24.1% (better) | −37.4% |
| Net margin | 18.1% (better) | −39.4% |
| FCF margin | −6.1% | – |
| Return on equity | 20.6% | – |
| Return on invested capital | −22.6% (better) | −53.4% |
| Financial health | ||
| Debt / equity | 0.15 | – |
| Interest coverage | −739.1× | −15.8× (better) |
| Current ratio | 2.99 (better) | 0.71 |
| Piotroski F-score | 5 (better) | 2 |
| Ownership | ||
| Held by institutions | 12.2% | 0.77% |
| Held by insiders | 37.1% | 68.1% |
| Insider net buying, 12 months | – | −$1.7M |
| Short interest, % of float | – | 2.5% |
Go deeper
- CRMN stock overview
- CRMN income statement
- CRMN valuation and score
- PMA stock overview
- PMA income statement
- PMA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.